AI Article Synopsis
- The text discusses a 74-year-old patient who developed serious neurological issues after a mild case of COVID-19, specifically highlighting two conditions: unilateral retrobulbar optic neuritis and acute inflammatory demyelinating polyneuropathy.
- The first condition (optic neuritis) occurred a few weeks after the patient had COVID-19, and notably, both conditions have not been previously reported in the same individual following the virus.
- The case is significant as it contributes to the growing body of literature on immune-related neurological complications linked to SARS-CoV-2 infection, especially concerning Myelin Oligodendrocyte Glycoprotein (MOG) antibodies.
Article Abstract
Post-infectious immune-mediated neurological complications of Sars-Cov-2 have been increasingly recognized since the novel pandemic emerged. We describe the case of a 74 years-old patient who developed a Myelin Oligodendrocyte Glycoprotein (MOG) antibody-associated unilateral retrobulbar optic neuritis a few weeks after paucisymptomatic COVID-19 disease and, subsequently, after the resolution of the optic neuritis, an acute inflammatory demyelinating polyneuropathy. So far, no cases of these two neurological manifestations have been reported in the same patient. We herein report a case characterized by both manifestations and review the accumulating literature regarding MOG antibody-associated disease following SarsCov-2 infection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779985 | PMC |
| http://dx.doi.org/10.1016/j.jneuroim.2022.578011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!